{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:58:03Z","timestamp":1785481083207,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40123-026-01425-x","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T17:12:48Z","timestamp":1782666768000},"page":"2545-2562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 Receptor Agonists and the Ocular Surface: A Narrative Review of Restoration, Remodeling, and Clinical Implications"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-0373","authenticated-orcid":false,"given":"Henry","family":"Bair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Orlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeba A.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"issue":"5","key":"1425_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/ICU.0000000000001137","volume":"36","author":"DL Zhang","year":"2025","unstructured":"Zhang DL, Finn AP. Glucagon-like peptide-1 receptor agonists and the eye. Curr Opin Ophthalmol. 2025;36(5):407\u201313. https:\/\/doi.org\/10.1097\/ICU.0000000000001137.","journal-title":"Curr Opin Ophthalmol"},{"key":"1425_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2025.12.007","author":"S Bala","year":"2025","unstructured":"Bala S, Allan KC, Decker NL, et al. Glucagon-like peptide-1 receptor agonists: what ophthalmologists need to know. Surv Ophthalmol. 2025. https:\/\/doi.org\/10.1016\/j.survophthal.2025.12.007.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"1425_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12886-025-04559-x","volume":"26","author":"Y Luo","year":"2026","unstructured":"Luo Y, Xia Y, Gong X, Hao M, Wei Q, Liao L. GLP-1 receptor agonists in eye disease: a comprehensive review of current research and future potential. BMC Ophthalmol. 2026;26(1):12. https:\/\/doi.org\/10.1186\/s12886-025-04559-x.","journal-title":"BMC Ophthalmol"},{"issue":"24","key":"1425_CR4","doi-asserted-by":"publisher","first-page":"8792","DOI":"10.3390\/jcm14248792","volume":"14","author":"D Kapantais","year":"2025","unstructured":"Kapantais D, Tsoutsanis P. Functional and aesthetic periorbital, ocular adnexal and ocular surface changes linked to GLP-1 receptor agonists. J Clin Med. 2025;14(24):8792. https:\/\/doi.org\/10.3390\/jcm14248792.","journal-title":"J Clin Med"},{"key":"1425_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ajo.2024.12.024","volume":"271","author":"DC Amaral","year":"2025","unstructured":"Amaral DC, Guedes J, Cruz MRB, et al. GLP-1 receptor agonists use and incidence of glaucoma: a systematic review and meta-analysis. Am J Ophthalmol. 2025;271:488\u201397. https:\/\/doi.org\/10.1016\/j.ajo.2024.12.024.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1425_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5005\/jp-journals-10078-1501","volume":"19","author":"MV Lang","year":"2025","unstructured":"Lang MV, Vasu P, Dorairaj EA, Bhartiya S, Dorairaj SK. Glaucoma risk reduction as a secondary benefit of glucagon-like peptide-1 receptor agonists: a review of emerging evidence. J Curr Glaucoma Pract. 2025;19(4):223\u20138. https:\/\/doi.org\/10.5005\/jp-journals-10078-1501.","journal-title":"J Curr Glaucoma Pract"},{"issue":"1","key":"1425_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/antiox13010120","volume":"13","author":"F Buonfiglio","year":"2024","unstructured":"Buonfiglio F, Wasielica-Poslednik J, Pfeiffer N, Gericke A. Diabetic keratopathy: redox signaling pathways and therapeutic prospects. Antioxidants. 2024;13(1):120. https:\/\/doi.org\/10.3390\/antiox13010120.","journal-title":"Antioxidants"},{"key":"1425_CR8","doi-asserted-by":"publisher","first-page":"762493","DOI":"10.3389\/fmed.2022.762493","volume":"9","author":"H Wu","year":"2022","unstructured":"Wu H, Fang X, Luo S, et al. Meibomian glands and tear film findings in type\u00a02 diabetic patients: a cross-sectional study. Front Med. 2022;9:762493. https:\/\/doi.org\/10.3389\/fmed.2022.762493.","journal-title":"Front Med"},{"issue":"1","key":"1425_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12886-023-02795-7","volume":"23","author":"Q Yang","year":"2023","unstructured":"Yang Q, Liu L, Li J, et al. Evaluation of meibomian gland dysfunction in type\u00a02 diabetes with dry eye disease: a non-randomized controlled trial. BMC Ophthalmol. 2023;23(1):44. https:\/\/doi.org\/10.1186\/s12886-023-02795-7.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"1425_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/aos.13844","volume":"97","author":"M Labetoulle","year":"2019","unstructured":"Labetoulle M, Baudouin C, Calonge M, et al. Role of corneal nerves in ocular surface homeostasis and disease. Acta Ophthalmol. 2019;97(2):137\u201345. https:\/\/doi.org\/10.1111\/aos.13844.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"1425_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.clinthera.2021.04.003","volume":"43","author":"IN Petropoulos","year":"2021","unstructured":"Petropoulos IN, Ponirakis G, Ferdousi M, et al. Corneal confocal microscopy: a biomarker for diabetic peripheral neuropathy. Clin Ther. 2021;43(9):1457\u201375. https:\/\/doi.org\/10.1016\/j.clinthera.2021.04.003.","journal-title":"Clin Ther"},{"issue":"4","key":"1425_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ajpath.2024.12.003","volume":"195","author":"Y Sun","year":"2025","unstructured":"Sun Y, Zhang Y, Shi F, et al. Characterization and role of glucagon-like peptide 1 receptor in the lacrimal gland: novel insights into diabetic dry eye pathogenesis. Am J Pathol. 2025;195(4):797\u2013810. https:\/\/doi.org\/10.1016\/j.ajpath.2024.12.003.","journal-title":"Am J Pathol"},{"key":"1425_CR13","doi-asserted-by":"publisher","first-page":"178264","DOI":"10.1016\/j.ejphar.2025.178264","volume":"1007","author":"W Han","year":"2025","unstructured":"Han W, Dai S, Sun X, et al. Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K\/AKT signalling pathway. Eur J Pharmacol. 2025;1007:178264. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178264.","journal-title":"Eur J Pharmacol"},{"key":"1425_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.freeradbiomed.2026.03.019","volume":"249","author":"X Zuo","year":"2026","unstructured":"Zuo X, Zeng H, Wang Y, et al. Semaglutide alleviates age-related dry eye disease by restoring lacrimal gland structure and function. Free Radic Biol Med. 2026;249:138\u201351. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2026.03.019.","journal-title":"Free Radic Biol Med"},{"key":"1425_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000003129","author":"PS Saffari","year":"2025","unstructured":"Saffari PS, Davila N, Pradeep T, Wong B, Lee WW. Periorbital changes following glucagon-like peptide-1 receptor agonist use: a retrospective cohort study of oculofacial complications and interventions. Ophthalmic Plast Reconstr Surg. 2025. https:\/\/doi.org\/10.1097\/IOP.0000000000003129.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"1425_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ohn.1209","volume":"173","author":"RK Sharma","year":"2025","unstructured":"Sharma RK, Vittetoe KL, Barna AJ, et al. Radiographic midfacial volume changes in patients on GLP-1 agonists. Otolaryngol Head Neck Surg. 2025;173(2):360\u20136. https:\/\/doi.org\/10.1002\/ohn.1209.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"1425_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s40123-022-00505-y","volume":"11","author":"B Schechter","year":"2022","unstructured":"Schechter B, Mah F. Optimization of the ocular surface through treatment of ocular surface disease before ophthalmic surgery: a narrative review. Ophthalmol Ther. 2022;11(3):1001\u201315. https:\/\/doi.org\/10.1007\/s40123-022-00505-y.","journal-title":"Ophthalmol Ther"},{"issue":"11","key":"1425_CR18","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1007\/s40123-025-01251-7","volume":"14","author":"G Coco","year":"2025","unstructured":"Coco G, Messmer EM, Starr CE, et al. A practical approach for optimizing ocular surface status before cataract surgery to improve visual outcomes and reduce the risk of postoperative dry eye. Ophthalmol Ther. 2025;14(11):2697\u2013733. https:\/\/doi.org\/10.1007\/s40123-025-01251-7.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"1425_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/ICU.0000000000001102","volume":"36","author":"KA Carvalho","year":"2025","unstructured":"Carvalho KA, Esporcatte LPG, Gomes RLR, Ambr\u00f3sio R Jr. Multimodal corneal imaging before refractive cataract surgery. Curr Opin Ophthalmol. 2025;36(1):25\u201334. https:\/\/doi.org\/10.1097\/ICU.0000000000001102.","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"1425_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/jdi.13643","volume":"13","author":"H Gad","year":"2022","unstructured":"Gad H, Petropoulos IN, Khan A, et al. Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: a systematic review and meta-analysis. J Diabetes Investig. 2022;13(1):134\u201347. https:\/\/doi.org\/10.1111\/jdi.13643.","journal-title":"J Diabetes Investig"},{"key":"1425_CR21","doi-asserted-by":"publisher","first-page":"1393105","DOI":"10.3389\/fnins.2024.1393105","volume":"18","author":"G Ponirakis","year":"2024","unstructured":"Ponirakis G, Al-Janahi I, Elgassim E, et al. Sustained corneal nerve loss predicts the development of diabetic neuropathy in type\u00a02 diabetes. Front Neurosci. 2024;18:1393105. https:\/\/doi.org\/10.3389\/fnins.2024.1393105.","journal-title":"Front Neurosci"},{"issue":"1","key":"1425_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10792-024-03043-7","volume":"44","author":"Z Akkul","year":"2024","unstructured":"Akkul Z, Erkilic K, Sener H, Polat OA, Er Arslantas E. Diabetic corneal neuropathy and its relation to the severity of retinopathy in patients with type\u00a02 diabetes mellitus: an in vivo confocal microscopy study. Int Ophthalmol. 2024;44(1):108. https:\/\/doi.org\/10.1007\/s10792-024-03043-7.","journal-title":"Int Ophthalmol"},{"issue":"6","key":"1425_CR23","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/biomedicines12061303","volume":"12","author":"LA Ghenciu","year":"2024","unstructured":"Ghenciu LA, Ha\u0163egan OA, Bolintineanu SL, et al. Immune-mediated ocular surface disease in diabetes mellitus-clinical perspectives and treatment: a narrative review. Biomedicines. 2024;12(6):1303. https:\/\/doi.org\/10.3390\/biomedicines12061303.","journal-title":"Biomedicines"},{"issue":"1","key":"1425_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10792-025-03865-z","volume":"46","author":"JC Quintana-P\u00e9rez","year":"2025","unstructured":"Quintana-P\u00e9rez JC, Tamay-Cach F, Guillen-Castro SA, et al. Alterations of the ocular surface during diabetes: molecular mechanisms and therapeutic strategies. Int Ophthalmol. 2025;46(1):3. https:\/\/doi.org\/10.1007\/s10792-025-03865-z.","journal-title":"Int Ophthalmol"},{"issue":"6","key":"1425_CR25","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.3390\/ijms25063471","volume":"25","author":"L Ladea","year":"2024","unstructured":"Ladea L, Zemba M, Calancea MI, et al. Corneal epithelial changes in diabetic patients: a review. Int J Mol Sci. 2024;25(6):3471. https:\/\/doi.org\/10.3390\/ijms25063471.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"1425_CR26","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1038\/s41433-024-03252-5","volume":"38","author":"Z Fang","year":"2024","unstructured":"Fang Z, Liu K, Pazo EE, et al. Clinical ocular surface characteristics and expression of MUC5AC in diabetics: a population-based study. Eye (Lond). 2024;38(16):3145\u201352. https:\/\/doi.org\/10.1038\/s41433-024-03252-5.","journal-title":"Eye (Lond)"},{"issue":"6","key":"1425_CR27","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/cells13060532","volume":"13","author":"PL Surico","year":"2024","unstructured":"Surico PL, Narimatsu A, Forouzanfar K, et al. Effects of diabetes mellitus on corneal immune cell activation and the development of keratopathy. Cells. 2024;13(6):532. https:\/\/doi.org\/10.3390\/cells13060532.","journal-title":"Cells"},{"issue":"9","key":"1425_CR28","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1111\/dom.13339","volume":"20","author":"JB Hebsgaard","year":"2018","unstructured":"Hebsgaard JB, Pyke C, Yildirim E, Knudsen LB, Heegaard S, Kvist PH. Glucagon-like peptide-1 receptor expression in the human eye. Diabetes Obes Metab. 2018;20(9):2304\u20138. https:\/\/doi.org\/10.1111\/dom.13339.","journal-title":"Diabetes Obes Metab"},{"issue":"20","key":"1425_CR29","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3390\/healthcare11202749","volume":"11","author":"YC Fan","year":"2023","unstructured":"Fan YC, Peng SY, Chang CK, et al. The utilization of glucagon-like peptide 1 agonists and risk of following external eye diseases in type\u00a02 diabetes mellitus individuals: a population-based study. Healthcare. 2023;11(20):2749. https:\/\/doi.org\/10.3390\/healthcare11202749.","journal-title":"Healthcare"},{"key":"1425_CR30","doi-asserted-by":"publisher","first-page":"980714","DOI":"10.3389\/fmed.2022.980714","volume":"9","author":"LY Pan","year":"2022","unstructured":"Pan LY, Kuo YK, Chen TH, Sun CC. Dry eye disease in patients with type\u00a0II diabetes mellitus: a retrospective, population-based cohort study in Taiwan. Front Med. 2022;9:980714. https:\/\/doi.org\/10.3389\/fmed.2022.980714.","journal-title":"Front Med"},{"issue":"9","key":"1425_CR31","doi-asserted-by":"publisher","first-page":"e2232584","DOI":"10.1001\/jamanetworkopen.2022.32584","volume":"5","author":"Y Su","year":"2022","unstructured":"Su Y, Hung J, Chang K, et al. Comparison of sodium-glucose cotransporter\u00a02 inhibitors vs glucagonlike peptide-1 receptor agonists and incidence of dry eye disease in patients with type\u00a02 diabetes in Taiwan. JAMA Netw Open. 2022;5(9):e2232584. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.32584.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1425_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1089\/jop.2024.0175","volume":"41","author":"CC Sun","year":"2025","unstructured":"Sun CC, Pan LY, Chen NN, Kuo YK, Chen TH. Risk and protective factors for ocular surface disease in patients with type\u00a02 diabetic mellitus: a retrospective cohort study. J Ocul Pharmacol Ther. 2025;41(6):322\u201331. https:\/\/doi.org\/10.1089\/jop.2024.0175.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1425_CR33","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.2147\/OPTH.S547776","volume":"19","author":"G Ottonelli","year":"2025","unstructured":"Ottonelli G, Gaeta A, Montericcio N, et al. GLP-1R agonists improve ocular surface parameters in type\u00a02 diabetes mellitus. Clin Ophthalmol. 2025;19:3829\u201336. https:\/\/doi.org\/10.2147\/OPTH.S547776.","journal-title":"Clin Ophthalmol"},{"key":"1425_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s43856-025-01066-4","volume":"5","author":"YN Huang","year":"2025","unstructured":"Huang YN, Chen JC, Li PH, et al. Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity. Commun Med. 2025;5:329. https:\/\/doi.org\/10.1038\/s43856-025-01066-4.","journal-title":"Commun Med"},{"issue":"3","key":"1425_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.survophthal.2019.11.003","volume":"65","author":"I Avisar","year":"2020","unstructured":"Avisar I, Nahum Y, Mimouni M, Kremer I, Malhotra R. Oculoplastic aspects of ocular surface disease and their management. Surv Ophthalmol. 2020;65(3):312\u201322. https:\/\/doi.org\/10.1016\/j.survophthal.2019.11.003.","journal-title":"Surv Ophthalmol"},{"issue":"23","key":"1425_CR36","doi-asserted-by":"publisher","first-page":"8523","DOI":"10.3390\/jcm14238523","volume":"14","author":"FM Quaranta Leoni","year":"2025","unstructured":"Quaranta Leoni FM, Marabottini N, Iuliano A, Strianese D, Savino G. Eyelid malpositions and ocular surface disease: clinical correlations and management strategies. J Clin Med. 2025;14(23):8523. https:\/\/doi.org\/10.3390\/jcm14238523.","journal-title":"J Clin Med"},{"issue":"4","key":"1425_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jtos.2018.06.001","volume":"16","author":"MTM Wang","year":"2018","unstructured":"Wang MTM, Tien L, Han A, et al. Impact of blinking on ocular surface and tear film parameters. Ocul Surf. 2018;16(4):424\u20139. https:\/\/doi.org\/10.1016\/j.jtos.2018.06.001.","journal-title":"Ocul Surf"},{"issue":"3","key":"1425_CR38","doi-asserted-by":"publisher","first-page":"102369","DOI":"10.1016\/j.clae.2025.102369","volume":"48","author":"MTM Wang","year":"2025","unstructured":"Wang MTM, Power B, Xue AL, Craig JP. Blink completeness and rate in dry eye disease: an investigator-masked, prospective registry-based, cross-sectional, prognostic study. Cont Lens Anterior Eye. 2025;48(3):102369. https:\/\/doi.org\/10.1016\/j.clae.2025.102369.","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"1425_CR39","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.4103\/IJO.IJO_2841_22","volume":"71","author":"P Narang","year":"2023","unstructured":"Narang P, Donthineni PR, D\u2019Souza S, Basu S. Evaporative dry eye disease due to meibomian gland dysfunction: preferred practice pattern guidelines for diagnosis and treatment. Indian J Ophthalmol. 2023;71(4):1348\u201356. https:\/\/doi.org\/10.4103\/IJO.IJO_2841_22.","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"1425_CR40","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.18240\/ijo.2023.12.01","volume":"16","author":"YH Zhang","year":"2023","unstructured":"Zhang YH, Feng J, Yi CY, et al. Dynamic tear meniscus parameters in complete blinking: insights into dry eye assessment. Int J Ophthalmol. 2023;16(12):1911\u20138. https:\/\/doi.org\/10.18240\/ijo.2023.12.01.","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"1425_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-0039-1685473","volume":"33","author":"AJ Guthrie","year":"2019","unstructured":"Guthrie AJ, Kadakia P, Rosenberg J. Eyelid malposition repair: a review of the literature and current techniques. Semin Plast Surg. 2019;33(2):92\u2013102. https:\/\/doi.org\/10.1055\/s-0039-1685473.","journal-title":"Semin Plast Surg"},{"key":"1425_CR42","doi-asserted-by":"publisher","first-page":"100547","DOI":"10.1016\/j.clinsp.2024.100547","volume":"80","author":"L Sbitan","year":"2025","unstructured":"Sbitan L, Tanous H, Jardak MN, Camargo CP. Towards optimal management of lower eyelid malpositions: a systematic review of treatment effectiveness and safety. Clinics (Sao Paulo). 2025;80:100547. https:\/\/doi.org\/10.1016\/j.clinsp.2024.100547.","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"1425_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.14744\/bej.2023.99266","volume":"8","author":"EC Yesilkaya","year":"2023","unstructured":"Yesilkaya EC, Ozyurek EBA, Dursun T, Dirim AB, Turker IC, Demir ST. The effects of blepharoptosis surgery on meibomian gland, tear film, and corneal topography. Beyoglu Eye J. 2023;8(3):214\u201320. https:\/\/doi.org\/10.14744\/bej.2023.99266.","journal-title":"Beyoglu Eye J"},{"issue":"2","key":"1425_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/IOP.0000000000002518","volume":"40","author":"SH Azzam","year":"2024","unstructured":"Azzam SH, Nama A, Hartstein M, Habib JH, Mukari A. The effect of ptosis surgery on meibomian glands and dry eye syndrome. Ophthalmic Plast Reconstr Surg. 2024;40(2):174\u20137. https:\/\/doi.org\/10.1097\/IOP.0000000000002518.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"1425_CR45","doi-asserted-by":"publisher","first-page":"e20220220","DOI":"10.5935\/0004-2749.2022-0220","volume":"87","author":"O Aygun","year":"2024","unstructured":"Aygun O, Arat OY, Dikmetas O, et al. Effect of upper eyelid blepharoplasty on the ocular surface, tear film, and corneal microstructure. Arq Bras Oftalmol. 2024;87(3):e20220220. https:\/\/doi.org\/10.5935\/0004-2749.2022-0220.","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"1425_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4274\/tjo.galenos.2021.63255","volume":"52","author":"NA Ceylan","year":"2022","unstructured":"Ceylan NA, Yeniad B. Effects of upper eyelid surgery on the ocular surface and corneal topography. Turk J Ophthalmol. 2022;52(1):50\u20136. https:\/\/doi.org\/10.4274\/tjo.galenos.2021.63255.","journal-title":"Turk J Ophthalmol"},{"key":"1425_CR47","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ajo.2025.10.021","volume":"281","author":"AS Ahuja","year":"2026","unstructured":"Ahuja AS, Paredes AA 3rd, Ahuja SA, Young BK. Glucagon-like peptide-1 receptor agonist use and risk of cataract development. Am J Ophthalmol. 2026;281:666\u201373. https:\/\/doi.org\/10.1016\/j.ajo.2025.10.021.","journal-title":"Am J Ophthalmol"},{"key":"1425_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ajo.2025.12.025","volume":"284","author":"BH Lin","year":"2026","unstructured":"Lin BH, Chuang SH, Wu LC, Chen YP, Kuo YJ, Chang CH. Association of sodium-glucose cotransporter\u00a02 inhibitors and glucagon-like peptide-1 receptor agonists with risk of cataract. Am J Ophthalmol. 2026;284:66\u201377. https:\/\/doi.org\/10.1016\/j.ajo.2025.12.025.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1425_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.aopr.2023.10.001","volume":"3","author":"Z Guo","year":"2023","unstructured":"Guo Z, Ma X, Zhang RX, Yan H. Oxidative stress, epigenetic regulation and pathological processes of lens epithelial cells underlying diabetic cataract. Adv Ophthalmol Pract Res. 2023;3(4):180\u20136. https:\/\/doi.org\/10.1016\/j.aopr.2023.10.001.","journal-title":"Adv Ophthalmol Pract Res"},{"issue":"12","key":"1425_CR50","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.jcrs.2017.10.033","volume":"43","author":"J Chuang","year":"2017","unstructured":"Chuang J, Shih KC, Chan TC, Wan KH, Jhanji V, Tong L. Preoperative optimization of ocular surface disease before cataract surgery. J Cataract Refract Surg. 2017;43(12):1596\u2013607. https:\/\/doi.org\/10.1016\/j.jcrs.2017.10.033.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"1425_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/ICU.0000000000000814","volume":"33","author":"X He","year":"2022","unstructured":"He X, Huang AS, Jeng BH. Optimizing the ocular surface prior to cataract surgery. Curr Opin Ophthalmol. 2022;33(1):9\u201314. https:\/\/doi.org\/10.1097\/ICU.0000000000000814.","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"1425_CR52","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.4103\/IJO.IJO_2465_20","volume":"68","author":"KP Vunnava","year":"2020","unstructured":"Vunnava KP, Shetty N, Kapur KB. A review of meibography for a refractive surgeon. Indian J Ophthalmol. 2020;68(12):2663\u20139. https:\/\/doi.org\/10.4103\/IJO.IJO_2465_20.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"1425_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/jns.12641","volume":"29","author":"H Gad","year":"2024","unstructured":"Gad H, Elgassim E, Lebbe A, et al. Corneal confocal microscopy detects early nerve regeneration after pharmacological and surgical interventions: systematic review and meta-analysis. J Peripher Nerv Syst. 2024;29(2):173\u201384. https:\/\/doi.org\/10.1111\/jns.12641.","journal-title":"J Peripher Nerv Syst"},{"key":"1425_CR54","doi-asserted-by":"publisher","unstructured":"Wolffsohn JS, Ben\u00edtez-Del-Castillo JM, Loya-Garcia D, et al., TFOS collaborator group. TFOS DEWS\u00a0III: diagnostic methodology. Am J Ophthalmol. 2025;279:387\u2013450. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.033.","DOI":"10.1016\/j.ajo.2025.05.033"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01425-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01425-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01425-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:04:29Z","timestamp":1785477869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01425-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1425"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01425-x","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Henry Bair, Molly Orlick, and Zeba A. Syed have no conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}